Skip to main content
SpringerLink
Log in

Congenital Fibrinogen Disorders

  • Chapter
  • First Online:
Congenital Bleeding Disorders

Abstract

Congenital fibrinogen disorders (CFD) are rare coagulation disorders. CFD can affect quantity (afibrinogenemia and hypofibrinogenemia), quality (dysfibrinogenemia), or both aspects (hypodysfibrinogenemia) of the fibrinogen molecule. The precise prevalence of CFD is not known, except for afibrinogenemia with an estimated incidence of 1 per 1,000,000 of person. Most patients with hypofibrinogenemia and dysfibrinogenemia are asymptomatic, while hemorrhage is frequent in afibrinogenemia often with umbilical cord bleeding at diagnosis. Thrombotic and obstetrical complications are also a common complication in patients with CFD. Diagnosis is based on the assessment of both antigenic and functional fibrinogen levels. In routine clinical use, the Clauss functional assay is recommended, although a variety of functional and antigenic assays with variable sensitivity are available. Genotype helps to confirm the diagnosis. A wide spectrum of mutations has been discovered in FGA, FGB, and FGG encoding the three chains of fibrinogen molecule. Two hotspot mutations are prevalent in afibrinogenemia and dysfibrinogenemia. Management of patients with congenital fibrinogen disorders is challenging and should always take in account the personal and familial history as well as the genotype in qualitative fibrinogen disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Neerman-Arbez M, De Moerloose P, Casini A. Laboratory and genetic investigation of mutations accounting for congenital fibrinogen disorders. Semin Thromb Hemost. 2016;42:356–65.

    Article  PubMed  CAS  Google Scholar 

  2. Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015;125(13):2052–61.

    Article  PubMed  CAS  Google Scholar 

  3. Casini A, De Moerloose P, Neerman-Arbez M. Clinical features and management of congenital fibrinogen deficiencies. Semin Thromb Hemost. 2016;42:366–74.

    Article  PubMed  Google Scholar 

  4. Dorgalaleh A, Alavi SER, Tabibian S, Soori S, Moradi EH, Bamedi T, et al. Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran. Hematology. 2017;22(4):224–30.

    Article  CAS  PubMed  Google Scholar 

  5. De Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013;39:585–95.

    Article  CAS  PubMed  Google Scholar 

  6. Menache D. Congenital fibrinogen abnormalities. Ann N Y Acad Sci. 1983;408(1):121–30.

    Article  PubMed  CAS  Google Scholar 

  7. Casini A, Neerman-Arbez M, Ariens R, Moerloose P. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost. 2015;13(6):909–19.

    Article  PubMed  CAS  Google Scholar 

  8. De Moerloose P, Neerman-Arbez M. Treatment of congenital fibrinogen disorders. Expert Opin Biol Ther. 2008;8(7):979–92.

    Article  PubMed  Google Scholar 

  9. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem. 1993;268:14116–24.

    PubMed  CAS  Google Scholar 

  10. Lee SY, Lee KP, Lim JW. Identification and biosynthesis of fibrinogen in human uterine cervix carcinoma cells. Thromb Haemost. 1996;75:466–70.

    Article  PubMed  CAS  Google Scholar 

  11. Simpson-Haidaris PJ. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood. 1997;89:873–82.

    CAS  Google Scholar 

  12. Francis CW, Nachman RL, Marder VJ. Plasma and platelet fibrinogen differ in gamma chain content. Thromb Haemost. 1984;51(1):84–8.

    Article  PubMed  CAS  Google Scholar 

  13. Soria J, Soria C, Samama M, Poirot E, Kling C. Human platelet fibrinogen: a protein different from plasma fibrinogen. Pathol Biol. 1976;24:15–7.

    PubMed  Google Scholar 

  14. Blombäck B. Fibrinogen structure, activation, polymerization and fibrin gel structure. Thromb Res. 1994;75(3):327–8.

    Article  PubMed  Google Scholar 

  15. Mosesson MW. Fibrinogen structure and fibrin clot assembly. Semin Thromb Hemost. 1998;24:169–74.

    Article  PubMed  CAS  Google Scholar 

  16. Söderqvist T, Blombäck B. Fibrinogen structure and evolution. Naturwissenschaften. 1971;58(1):16–23.

    Article  PubMed  Google Scholar 

  17. Fish RJ, Neerman-Arbez M. Fibrinogen gene regulation. Thromb Haemost. 2012;108(3):419–26.

    PubMed  CAS  Google Scholar 

  18. Crabtree GR, Comeau CM, Fowlkes DM, Fornace AJ, Malley JD, Kant JA. Evolution and structure of the fibrinogen genes: random insertion of introns or selective loss? J Mol Biol. 1985;185(1):1–19.

    Article  PubMed  CAS  Google Scholar 

  19. Henry I, Uzan G, Weil D, Nicolas H, Kaplan J, Marguerie C, et al. The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am J Hum Genet. 1984;36(4):760.

    PubMed  PubMed Central  CAS  Google Scholar 

  20. Asselta R, Duga S, Tenchini M. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost. 2006;4(10):2115–29.

    Article  CAS  PubMed  Google Scholar 

  21. Macrae FL, Domingues MM, Casini A, Ariëns RA. The (Patho)physiology of fibrinogen γ′. Semin Thromb Hemost. 2016;42(4):344–55.

    Article  PubMed  CAS  Google Scholar 

  22. De Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders. Semin Thromb Hemost. 2009;35:356–66.

    Article  CAS  PubMed  Google Scholar 

  23. Neerman-Arbez M, Tirefort Y, de Moerloose P. Can mutations identified in congenital fibrinogen disorders explain the clinical manifestations. J Coagul Disord. 2010;2(2):1–9.

    Google Scholar 

  24. Stanciakova L, Kubisz P, Dobrotova M, Stasko J. Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management. Expert Rev Hematol. 2016;9(7):639–48.

    Article  PubMed  CAS  Google Scholar 

  25. Ogata Y, Hepplmann CJ, Charlesworth MC, Madden BJ, Miller MN, Kalli KR, et al. Elevated levels of phosphorylated fibrinogen-α-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients. J Proteome Res. 2006;5(12):3318–25.

    Article  PubMed  CAS  Google Scholar 

  26. Parastatidis I, Thomson L, Burke A, Chernysh I, Nagaswami C, Visser J, et al. Fibrinogen β-chain tyrosine nitration is a prothrombotic risk factor. J Biol Chem. 2008;283(49):33846–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Medved L, Weisel JW, Fibrinogen and Factor XIII Subcommittee of Scientific Standardization Committee of International Society on Thrombosis and Haemostasis. Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost. 2009;7(2):355–9.

    Article  PubMed  CAS  Google Scholar 

  28. Mosesson M. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3(8):1894–904.

    Article  PubMed  CAS  Google Scholar 

  29. Olexa SA, Budzynski AZ. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci. 1980;77(3):1374–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Gorkun OV, Veklich YI, Medved LV, Henschen AH, Weisel JW. Role of the alpha C domains of fibrin in clot formation. Biochemistry. 1994;33(22):6986–97.

    Article  PubMed  CAS  Google Scholar 

  31. Li X, Galanakis D, Gabriel DA. Transient intermediates in the thrombin activation of fibrinogen evidence for only the desAA species. J Biol Chem. 1996;271(20):11767–71.

    Article  PubMed  CAS  Google Scholar 

  32. Dorgalaleh A, Rashidpanah J. Blood coagulation factor XIII and factor XIII deficiency. Blood Rev. 2016;30(6):461–75.

    Article  CAS  PubMed  Google Scholar 

  33. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res. 1999;94(5):271–305.

    Article  PubMed  CAS  Google Scholar 

  34. Muszbek L, Adany R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci. 1996;33(5):357–421.

    Article  PubMed  CAS  Google Scholar 

  35. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL. Wound-healing defects in mice lacking fibrinogen. Blood. 2001;97(12):3691–8.

    Article  PubMed  CAS  Google Scholar 

  36. Clark RA. Fibrin and wound healing. Ann N Y Acad Sci. 2001;936(1):355–67.

    Article  PubMed  CAS  Google Scholar 

  37. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Investig. 1991;87(4):1234.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  38. Staton CA, Brown NJ, Lewis CE. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther. 2003;3(7):1105–20.

    Article  PubMed  CAS  Google Scholar 

  39. Rybarczyk BJ, Lawrence SO, Simpson-Haidaris PJ. Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood. 2003;102(12):4035–43.

    Article  PubMed  CAS  Google Scholar 

  40. Suh TT, Holmbäck K, Jensen NJ, Daugherty CC, Small K, Simon DI, et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 1995;9(16):2020–33.

    Article  PubMed  CAS  Google Scholar 

  41. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell. 1989;58(5):945–53.

    Article  PubMed  CAS  Google Scholar 

  42. Peyvandi F. Epidemiology and treatment of congenital fibrinogen deficiency. Thromb Res. 2012;130:S7–S11.

    Article  PubMed  CAS  Google Scholar 

  43. El Boussaadni Y, Benajiba N, El Ouali A, Amrani R, Rkain M. Congenital afibrinogenemia: a case report. Archives de pediatrie: organe officiel de la Societe francaise de. Pediatrie. 2015;22(1):50–2.

    Google Scholar 

  44. Peyvandi F, Palla R, Menegatti M, Siboni S, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10(4):615–21.

    Article  PubMed  CAS  Google Scholar 

  45. Peyvandi F, Di Michele D, Bolton-Maggs P, Lee C, Tripodi A, Srivastava A. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost. 2012;10(9):1938–43.

    Article  CAS  PubMed  Google Scholar 

  46. Lebreton A, Casini A. Diagnosis of congenital fibrinogen disorders. Ann Biol Clin. 2016;74:405–12.

    Google Scholar 

  47. Cunningham MT, Brandt JT, Laposata M, Olson JD. Laboratory diagnosis of dysfibrinogenemia. Arch Pathol Lab Med. 2002;126(4):499–505.

    PubMed  Google Scholar 

  48. Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res. 2010;126(6):e428–e33.

    Article  PubMed  CAS  Google Scholar 

  49. Al-Mondhiry H, Ehmann WC. Congenital afibrinogenemia. Am J Hematol. 1994;46(4):343–7.

    Article  PubMed  CAS  Google Scholar 

  50. Henselmans J, Meijer K, Haaxma R, Hew J, van Der Meer J. Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient. Stroke. 1999;30(11):2479–82.

    Article  PubMed  CAS  Google Scholar 

  51. Taslimi R, Golshani K. Thrombotic and hemorrhagic presentation of congenital hypo/afibrinogenemia. Am J Emerg Med. 2011;29(5):573.e3–5.

    Article  Google Scholar 

  52. Paolini R, Sartori MT, Fiorin F, Gorinati M, Boeri G, Girolami A. Perinatal intracranial hemorrhage as first manifestation of congenital hypofibrinogenemia. Clin Appl Thromb Hemost. 1996;2(1):60–3.

    Article  Google Scholar 

  53. Fettah A, Gökçebay DG, Çulha V, Yaralı N, Tunç B, Özbek N. A rare complication of congenital afibrinogenemia: bone cysts. Turk J Haematol. 2017;34(2):183.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Ehmann WC, Al-Mondhiry H. Congenital afibrinogenemia and splenic rupture. Am J Med. 1994;96(1):92–4.

    Article  PubMed  CAS  Google Scholar 

  55. Dorgalaleh A, Naderi M, Shamsizadeh M. Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency. Ann Hematol. 2016;95(3):451–5.

    Article  CAS  PubMed  Google Scholar 

  56. Trehan A, Fergusson I. Congenital afibrinogenaemia and successful pregnancy outcome. Case report. Br J Obstet Gynaecol. 1991;98(7):722–4.

    Article  PubMed  CAS  Google Scholar 

  57. Zdziarska J, Undas A, Basa J, Iwaniec T, Skotnicki AB, De Moerloose P, et al. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the γAla82Gly mutation. Blood Coagul Fibrinolysis. 2009;20(5):374–6.

    Article  PubMed  CAS  Google Scholar 

  58. Santoro C, Massaro F, Venosi S, Capria S, Baldacci E, Foà R, Mazzucconi MG. Severe thrombotic complications in congenital afibrinogenemia: a pathophysiological and management dilemma. Semin Thromb Hemost. 2016;42(5):577–82.

    Article  PubMed  CAS  Google Scholar 

  59. Rottenstreich A, Lask A, Schliamser L, Zivelin A, Seligsohn U, Kalish Y. Thromboembolic events in patients with severe inherited fibrinogen deficiency. J Thromb Thrombolysis. 2016;42(2):261–6.

    Article  PubMed  CAS  Google Scholar 

  60. Sartori MT, Milan M, de Bon E, Fadin M, Pesavento R, Zanon E. Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature. Haemophilia. 2015;21(1):88–94.

    Article  PubMed  CAS  Google Scholar 

  61. Frenkel E, Duksin C, Herman A, Sherman DJ. Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the literature. Obstet Gynecol Surv. 2004;59(11):775–9.

    Article  PubMed  Google Scholar 

  62. Awasthy N, Aggarwal K, Gupta H, Saluja S. Congenital hypofibrinogenemia. Indian Pediatr. 2004;41(2):185–6.

    PubMed  Google Scholar 

  63. Hasselback R, Marion RB, Thomas J. Congenital hypofibrinogenemia in five members of a family. Can Med Assoc J. 1963;88(1):19.

    PubMed  PubMed Central  CAS  Google Scholar 

  64. Bay A, Coskun E, Leblebisatan G, Sivasli E. Epidural hematoma and cephalohematoma with congenital hypofibrinogenemia. Blood Coagul Fibrinolysis. 2012;23(3):229–31.

    Article  PubMed  Google Scholar 

  65. Rubbia-Brandt L, Neerman-Arbez M, Rougemont A-L, Malé P-J, Spahr L. Fibrinogen gamma375 arg→ trp mutation (fibrinogen aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reticulum storage disease and cirrhosis. Am J Surg Pathol. 2006;30(7):906–11.

    Article  PubMed  Google Scholar 

  66. Wehinger H, Klinge O, Alexandrakis E, Schürmann J, Witt J, Seydewitz H. Hereditary hypofibrinogenemia with fibrinogen storage in the liver. Eur J Pediatr. 1983;141(2):109–12.

    Article  PubMed  CAS  Google Scholar 

  67. Pfeifer U, Ormanns W, Klinge O. Hepatocellular fibrinogen storage in familial hypofibrinogenemia. Virchows Arch B. 1981;36(1):247–55.

    Article  PubMed  CAS  Google Scholar 

  68. Casini A, Sokollik C, Lukowski S, Lurz E, Rieubland C, Moerloose P, et al. Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature. Haemophilia. 2015;21(6):820–7.

    Article  PubMed  CAS  Google Scholar 

  69. Asselta R, Robusto M, Braidotti P, Peyvandi F, Nastasio S, D’antiga L, et al. Hepatic fibrinogen storage disease: identification of two novel mutations (p. Asp316Asn, fibrinogen Pisa and p. Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module. J Thromb Haemost. 2015;13(8):1459–67.

    Article  PubMed  CAS  Google Scholar 

  70. Puls F, Goldschmidt I, Bantel H, Agne C, Bröcker V, Dämmrich M, et al. Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage disease. J Hepatol. 2013;59(3):626–30.

    Article  PubMed  CAS  Google Scholar 

  71. Casini A, Duval C, Pan X, Tintillier V, Biron-Andreani C, Ariëns R. Fibrin clot structure in patients with congenital dysfibrinogenaemia. Thromb Res. 2016;137:189–95.

    Article  PubMed  CAS  Google Scholar 

  72. Casini A, Blondon M, Lebreton A, Koegel J, Tintillier V, de Maistre E, et al. Natural history of patients with congenital dysfibrinogenemia. Blood. 2015;125(3):553–61.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Miesbach W, Galanakis D, Scharrer I. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy. Blood Coagul Fibrinolysis. 2009;20(5):366–70.

    Article  PubMed  CAS  Google Scholar 

  74. Miesbach W, Scharrer I, Henschen A, Neerman-Arbez M, Spitzer S, Galanakis D. Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects. Blood Coagul Fibrinolysis. 2010;21(1):35–40.

    Article  PubMed  CAS  Google Scholar 

  75. Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med. 2002;126(11):1387–90.

    PubMed  Google Scholar 

  76. Rowczenio D, Stensland M, de Souza GA, Strøm EH, Gilbertson JA, Taylor G, et al. Renal amyloidosis associated with five novel variants in the fibrinogen A alpha chain protein. Kidney Int Rep. 2017;2:461–9.

    Article  PubMed  Google Scholar 

  77. Casini A, Brungs T, Lavenu-Bombled C, Vilar R, Neerman-Arbez M, Moerloose P. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. J Thromb Haemost. 2017;15(5):876–88.

    Article  PubMed  CAS  Google Scholar 

  78. Deering SH, Landy HJ, Tchabo N, Kessler C. Hypodysfibrinogenemia during pregnancy, labor, and delivery. Obstet Gynecol. 2003;101(5, Part 2):1092–4.

    Article  PubMed  Google Scholar 

  79. Cheah CY, Brennan SO, Kennedy H, Januszewicz EH, Maxwell E, Burbury K. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis. Blood Coagul Fibrinolysis. 2012;23(6):563–5.

    Article  PubMed  CAS  Google Scholar 

  80. Ebert RF, Bell WR. Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis. Proc Natl Acad Sci. 1983;80(23):7318–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  81. Lefebvre P, Velasco PT, Dear A, Lounes KC, Lord ST, Brennan SO, et al. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AαIVS4+ 1G> T mutation and an AαGln328 truncation (fibrinogen Keokuk). Blood. 2004;103(7):2571–6.

    Article  PubMed  CAS  Google Scholar 

  82. Jayo A, Arnold E, González-Manchón C, Green D, Lord ST. Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AαIVS4+ 1G> T mutation and Aα4841delC truncation (AαPerth). Thromb Haemost. 2009;101(4):770.

    PubMed  PubMed Central  CAS  Google Scholar 

  83. Duga S, Asselta R, Santagostino E, Zeinali S, Simonic T, Malcovati M, et al. Missense mutations in the human β fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood. 2000;95(4):1336–41.

    PubMed  CAS  Google Scholar 

  84. Neerman-Arbez M, De Moerloose P, Bridel C, Honsberger A, Schönbörner A, Rossier C, et al. Mutations in the fibrinogen Aα gene account for the majority of cases of congenital afibrinogenemia. Blood. 2000;96(1):149–52.

    PubMed  CAS  Google Scholar 

  85. Neerman-Arbez M. The molecular basis of inherited afibrinogenaemia. Thromb Haemost. 2001;86(1):154–63.

    CAS  PubMed  Google Scholar 

  86. Uzan G, Courtois G, Besmond C, Frain M, Sala-Trepat J, Kahn A, et al. Analysis of fibrinogen genes in patients with congenital afibrinogenemia. Biochem Biophys Res Commun. 1984;120(2):376–83.

    Article  PubMed  CAS  Google Scholar 

  87. Neerman-Arbez M, De Moerloose P. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations. Hum Mutat. 2007;28(6):540.

    Article  PubMed  CAS  Google Scholar 

  88. Brennan SO, Fellowes AP, George PM. Molecular mechanisms of hypo-and afibrinogenemia. Ann N Y Acad Sci. 2001;936(1):91–100.

    Article  PubMed  CAS  Google Scholar 

  89. Neerman-Arbez M, De Moerloose P, Honsberger A, Parlier G, Arnuti B, Biron C, et al. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes. Hum Genet. 2001;108(3):237–40.

    Article  PubMed  CAS  Google Scholar 

  90. Neerman-Arbez M, Vu D, Abu-Libdeh B, Bouchardy I, Morris MA. Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family. Blood. 2003;101(9):3492–4.

    Article  PubMed  CAS  Google Scholar 

  91. Asselta R, Spena S, Duga S, Peyvandi F, Malcovati M, Mannucci PM, et al. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia. Haematologica. 2002;87(8):855–9.

    PubMed  CAS  Google Scholar 

  92. Brennan SO, Davis RL, Conard K, Savo A, Furuya KN. Novel fibrinogen mutation γ314Thr→ Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia. Liver Int. 2010;30(10):1541–7.

    Article  PubMed  CAS  Google Scholar 

  93. Lee MJ, Venick R, Bhuta S, Li X, Wang HL. Hepatic fibrinogen storage disease in a patient with hypofibrinogenemia: report of a case with a missense mutation of the FGA gene. Semin Liver Dis. 2015;35:439–43.

    Article  PubMed  CAS  Google Scholar 

  94. Asselta R, Platè M, Robusto M, Borhany M, Guella I, Soldà G, et al. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency. Thromb Haemost. 2015;113(3):567–76.

    Article  PubMed  Google Scholar 

  95. Sumitha E, Jayandharan G, Arora N, Abraham A, David S, Devi G, et al. Molecular basis of quantitative fibrinogen disorders in 27 patients from India. Haemophilia. 2013;19(4):611–8.

    Article  PubMed  CAS  Google Scholar 

  96. Koopman J, Haverkate F, Grimbergen J, Egbring R, Lord S. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA--> stop TAA). Blood. 1992;80(8):1972–9.

    PubMed  CAS  Google Scholar 

  97. Vu D, Neerman-Arbez M. Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins. J Thromb Haemost. 2007;5(s1):125–31.

    Article  CAS  PubMed  Google Scholar 

  98. Zhou J, Ding Q, Chen Y, Ouyang Q, Jiang L, Dai J, et al. Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia. Blood Cell Mol Dis. 2015;55(4):308–15.

    Article  CAS  Google Scholar 

  99. Hill M, Dolan G. Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias. Haemophilia. 2008;14(5):889–97.

    Article  PubMed  CAS  Google Scholar 

  100. Verhovsek M, Moffat KA, Hayward CP. Laboratory testing for fibrinogen abnormalities. Am J Hematol. 2008;83(12):928–31.

    Article  PubMed  Google Scholar 

  101. Sadeghian MH, Keramati MR, Badiei Z, Ravarian M, Ayatollahi H, Rafatpanah H, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci. 2009;3(2):95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  102. Ridgway HJ, Brennan SO, Faed JM, George PM. Fibrinogen Otago: a major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br J Haematol. 1997;98(3):632–9.

    Article  PubMed  CAS  Google Scholar 

  103. Martinez J, Holburn R, Shapiro S, Erslev A. Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. J Clin Investig. 1974;53(2):600.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  104. Mukai S, Nagata K, Ikeda M, Arai S, Sugano M, Honda T, et al. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c. 1129+ 62_65 del AATA and FGG c. 1299+ 4 del A. Thromb Res. 2016;148:111–7.

    Article  PubMed  CAS  Google Scholar 

  105. Harr JN, Moore EE, Ghasabyan A, Chin TL, Sauaia A, Banerjee A, et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock. 2013;39(1):45.

    PubMed  PubMed Central  CAS  Google Scholar 

  106. Mackie I, Lawrie A, Kitchen S, Gaffney P, Howarth D, Lowe G, et al. A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thromb Haemost. 2002;87(6):997–1005.

    Article  PubMed  CAS  Google Scholar 

  107. Mackie IJ, Kitchen S, Machin SJ, Lowe G. Guidelines on fibrinogen assays. Br J Haematol. 2003;121(3):396–404.

    Article  PubMed  Google Scholar 

  108. Exner T, Burridge J, Power P, Rickard KA. An evaluation of currently available methods for plasma fibrinogen. Am J Clin Pathol. 1979;71(5):521–7.

    Article  PubMed  CAS  Google Scholar 

  109. Desvignes P, Bonnet P. Direct determination of plasma fibrinogen levels by heat precipitation. A comparison of the technique against thrombin clottable fibrinogen with spectrophotometry and radial immuno-diffusion. Clin Chim Acta. 1981;110(1):9–17.

    Article  PubMed  CAS  Google Scholar 

  110. Besser MW, MacDonald SG. Acquired hypofibrinogenemia: current perspectives. J Blood Med. 2016;7:217.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  111. Casini A, de Moerloose P. Can the phenotype of inherited fibrinogen disorders be predicted? Haemophilia. 2016;22(5):667–75.

    Article  PubMed  CAS  Google Scholar 

  112. Shapiro SE, Phillips E, Manning RA, Morse CV, Murden SL, Laffan MA, et al. Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia. Br J Haematol. 2013;160(2):220–7.

    Article  PubMed  CAS  Google Scholar 

  113. Godal H, Brosstad F, Kierulf P. Three new cases of an inborn qualitative fibrinogen defect (Fibrinogen Oslo II). Eur J Haematol. 1978;20(1):57–62.

    CAS  Google Scholar 

  114. Acharya S, Coughlin A, Dimichele DM. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost. 2004;2(2):248–56.

    Article  CAS  PubMed  Google Scholar 

  115. Casini A, de Moerloose P, Congenital Fibrinogen Disorders Group. Management of congenital quantitative fibrinogen disorders: a Delphi consensus. Haemophilia. 2016;22(6):898–905.

    Article  PubMed  CAS  Google Scholar 

  116. Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, et al. Guideline for the diagnosis and management of the rare coagulation disorders. Br J Haematol. 2014;167(3):304–26.

    Article  CAS  PubMed  Google Scholar 

  117. Bolton-Maggs PH, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, Collins PW, Kitchen S, Dolan G, Mumford AD. The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia. 2004;10(5):593–628.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

    Akbar Dorgalaleh

  2. Division of Angiology and Haemostasis, Faculty of Medicine, University Hospitals of Geneva, Geneva, Switzerland

    Alessandro Casini

  3. Department of Hematology and Blood Transfusion, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Parvin Rahmani

Authors
  1. Akbar Dorgalaleh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro Casini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Parvin Rahmani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Casini .

Editor information

Editors and Affiliations

  1. Iran University of Medical Sciences, Departement of Hematology and Blood TransfusionSchool of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

    Akbar Dorgalaleh

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dorgalaleh, A., Casini, A., Rahmani, P. (2018). Congenital Fibrinogen Disorders. In: Dorgalaleh, A. (eds) Congenital Bleeding Disorders . Springer, Cham. https://doi.org/10.1007/978-3-319-76723-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-76723-9_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-76722-2

  • Online ISBN: 978-3-319-76723-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation